10-K Decoder · All companies

CytomX Therapeutics, Inc.

CTMX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$76.2M$138M−44.8%
Operating income−$22.4M$25.0M
Net income−$20.4M$31.9M

Questions

What was CytomX's revenue in FY2025?
$76.2M in FY2025 (Fiscal year ended Dec 31, 2025), −44.8% vs $138M a year earlier, per its 10-K filed Mar 2026.
Was CytomX profitable in FY2025?
No: net income was −$20.4M and operating income −$22.4M in FY2025.